Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome

Abstract Background Schistosomiasis is a neglected tropical disease burdening millions of people. One drug, praziquantel, is currently used for treatment and control. Clinically relevant drug resistance has not yet been described, but there is considerable heterogeneity in treatment outcomes, rangin...

Full description

Bibliographic Details
Main Authors: Pierre H. H. Schneeberger, Jean T. Coulibaly, Gordana Panic, Claudia Daubenberger, Morgan Gueuning, Jürg E. Frey, Jennifer Keiser
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Parasites & Vectors
Subjects:
Schistosoma mansoni
Praziquantel
Gut microbiome
Infectious disease
Microbiome-parasite interaction
Microbiome-drug interaction
Online Access:http://link.springer.com/article/10.1186/s13071-018-2739-2

Internet

http://link.springer.com/article/10.1186/s13071-018-2739-2

Similar Items